Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: A new clinical challenge

Clinical Infectious Diseases

Volumn 43, Issue 11, 2006, Pages 1407-1414

  Rodriguez Baño, Jesús ^a,b   Navarro, Maria D ^a   Romero, Luisa ^a   Muniain, Miguel A ^a,b   De Cueto, Marina ^a   Ríos, María J ^a   Hernández, José R ^a   Pascual, Alvaro ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BILE DUCT OBSTRUCTION; CLINICAL ARTICLE; DIABETES MELLITUS; DISEASE PREDISPOSITION; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HUMAN; INTRAVENOUS CATHETER; MALE; MORTALITY; MULTIDRUG RESISTANCE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SURGICAL PATIENT; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE CATHETER;

ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CEPHALOSPORINS; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; PENICILLANIC ACID; PIPERACILLIN;

EID: 33751566651     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/508877     Document Type: Article

References (42)

1. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18:657-86.
2. Bonnet R. Growing group of extended-spectrum beta-lactamase: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48:1-14.
3. Romero L, López. L, Rodríguez-Baño J, Hernández, JR, Martínez-Martínez. L, Pascual A. Long-term study of the frequency of ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates. Clin Microbiol Infect 2005; 11:625-31.
4. Pitout JD, Gregson DB, Church DL, Elsayed S, Laupland KB. Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region. J Clin Microbiol 2005;43:2844-9.
5. Woodford N, Ward ME, Kaufmann ME, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2004;54:735-43.
6. Hernández JR, Pascual A, Cantón R, Martínez- Martínez L, Grupo de Estudio de Infección Hospitalaria (GEIH). Escherichia coli y Klebsiella pneumoniae productores de betalactamasas de espectro extendido en hospitales españoles (proyecto GEIH-BLEE 2000). Enferm Infecc Microbiol Clin 2003; 21:77-82.
7. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005; 56:52-9.
8. Rodríguez-Baño J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42:1089-94.
9. Rodríguez-Baño J, Navarro MD, Romero L, et al. Clinical and molecular epidemiology of extended-spectrum beta-lactamase producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006; 42:37-45.
10. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 5th ed. Philadelphia: Churchill Livingston, 2000:773-805.
11. Lipsky AB, Berendt AR, Deery G, et al. Diagnosis and treatment of diabetic food infections. Clin Infect Dis 2004; 39:883-910.
12. Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003; 37:997-1005.
13. McCabe WR, Jackson GG. Gram-negative bacteremia I. Etiology and ecology. Arch Intern Med 1962; 110:847-55.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40:373-83.
15. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-40.
16. Paterson DL, Wen-Chien K, Von Gottberg A, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004; 140:26-32.
17. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
18. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definations of community-acquired bacteremia. Ann Intern Med 2002; 137:791-7.
19. CLSI. Performance standards for antimicrobial susceptibility testing, 15th informational supplement. Approved standard M 100-S15. Wayne, PA: CLSI, 2005.
20. Vila J, Marcos MA, Jiménez de Anta MT. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J Med Microbiol 1996;44:482-9.
21. Barret TJ, Lior H, Green JH, et al. Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J Clin Microbiol 1994; 33:3013-7.
22. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electropboresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
23. Matthew M, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 1975;88:169-78.
24. Bush K, Singer SB. Effective cooling allows sonication to be used for liberation of β-lactamases from gram-negative bacteria. J Antimicrob Chemother 1989; 24:82-4.
25. Jacoby J, Bush K. Amino acid sequences for TEM, SHV, and OXA extended-spectrum and inhibitor resistant β-lactamases. Available at: http://www.lahey.org/studies/webt.htm. Accessed 15 May 2006.
26. Coque TM, Oliver A, Perez-Diaz JC, Baquero F, Canton R. Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum β-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob Agents Chemother 2002; 46:500-10.
27. Rasheed JK, Jay C, Metchock B, et al. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemothcr 1997; 41:647-53.
28. Simarro E, Navarro F, Ruiz J, Miro E, Gomez J, Mirellis B. Salmonella enterica serovar Virchow with CTX-M-like beta-lactamase in Spain. J Clin Microbiol 2000; 38:4676-8.
29. National Institute of Health. Basic Local Alignment Search Tool (BLAST). Available at: http://www.ncbi.ntm.nih.gov/BLAST. Accessed 15 May 2006.
30. Infobiogen. Traduction multiple. Available at: http://www.infobiogen.fr/ services/analyseq/cgi-bin. Accessed 15 May 2006.
31. Paterson DL, Ko WC, Von Gottberg A, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001; 39:2206-12.
32. Hyle EP, Adam DL, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae. Arch Intern Med 2005; 165:1375-80.
33. Rodríguez-Baño J, Paterson DL. A change in the epidemiology of infections due to extended-spectrum β-lactamase-producing organisms. Clin Infect Dis 2006; 42:935-7.
34. Pak-Leung H, Wai-Ming C, Tsang KWT, Wong SSY, Yuong K. Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes. Scand J Infect Dis 2002;34:567-73.
35. Metan G, Zarakolu P, Cakir B, Hascelik C, Uzun O. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents 2005; 26:254-7.
36. Du B, Long Y, Liu H, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002; 28:1718-23.
37. Tumbarello M, Spanu T, Sanguineti M, et al. Bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 2006; 50:498-504.
38. Endimiani A, Luzzaro F, Perilli M, et al. Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum-β-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin. Clin Infect Dis 2004;38:243-51.
39. Ben-Ami R, Schwaber MJ, Navon-Venezia S, et al. Influx of extended-spectrum-β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006;42:925-34.
40. Romero Perez L, Lopez L, Rodríguez-Bano J, Pascual A. Effect of inoculum size on the activity of betalactams and betalactam-inhibitors against SHV-, TEM-, and CTX-M-producing Enterobacteriaccae [abstract P473]. 15th European Congress of Clinical Microbiology and Infectious Diseases (Copenhagen, Denmark). Clin Microbiol Infect 2005; 11(Suppl 2):122.
41. Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antimicrobial armamentarium. Arch Intern Med 2005; 165:1430-5.
42. Wisplinghoff H, Bischoff T, Talent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide study. Clin Infect Dis 2004; 39:309-17.